Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Earnings Overview
As of November 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported trailing twelve-month net income of -$10M, reflecting +99.2% year-over-year growth. The company earned $-10.11 per diluted share over the past four quarters.
Looking at the long-term picture, SHPH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$213,594 in fiscal 2017.
Shuttle Pharmaceuticals Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SENS (-$109M net income, -196.0% margin), NVCR (-$122M net income, -20.8% margin), AGEN ($28M net income, 0.1% margin), SHPH has comparable earnings metrics. Compare SHPH vs SENS →
SHPH Earnings vs Peers
Earnings metrics vs comparable public companies
SHPH Historical Earnings Data (2017–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | -28.2% | -$12M | $-71.60 | - | - |
| 2024 | -$9M | -38.7% | -$8M | $-8857.30 | - | - |
| 2023 | -$7M | -32.0% | -$6M | $-4.10 | - | - |
| 2022 | -$5M | -333.6% | -$2M | $-3.00 | - | - |
| 2021 | -$1M | -43.0% | -$2M | $-0.94 | - | - |
| 2020 | $-805,732 | -28.7% | $-509,522 | $-0.68 | - | - |
| 2018 | $-626,139 | -193.1% | $-586,630 | $-0.46 | - | - |
| 2017 | $-213,594 | - | $-203,890 | $-0.16 | - | - |
Download Data
Export SHPH earnings history in CSV or JSON format
Free sign-in required to download data
SHPH Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SHPH — Frequently Asked Questions
Quick answers to the most common questions about buying SHPH stock.
What is SHPH earnings per share (EPS)?
SHPH trailing twelve-month (TTM) diluted EPS is $-10.11, reflecting +99.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Shuttle Pharmaceuticals Holdings, Inc.'s net income?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trailing twelve-month net income is $-10M as of 2025. Earnings grew +99.2% year-over-year.
Is SHPH profitable?
SHPH is not currently profitable on a TTM basis, reporting a net loss of $-10M. Net margin is N/A. Investors should monitor for a return to profitability.
What is SHPH's earnings growth rate?
SHPH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are SHPH's profit margins?
Shuttle Pharmaceuticals Holdings, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -791.0%.
Is SHPH growing earnings?
Yes, SHPH earnings are accelerating — EPS growth of +99.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-10M. Earnings momentum is strengthening.
What was SHPH's best earnings year?
Shuttle Pharmaceuticals Holdings, Inc.'s highest annual net income on record is $-213594.00, achieved in fiscal year 2017. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were SHPH's earnings last quarter?
SHPH's most recent reported quarter was Q2 2026. Net income was $-3M with diluted EPS of $-3.10. For a full breakdown of all quarters, see the quarterly earnings table on this page.